Table 3.
Outcome: CDAI point remission | |||
---|---|---|---|
RA duration<=2 years | |||
Variable | Odds ratio (OR) |
95% CI | p value |
Sex* | 0.86 | 0.59 – 1.21 | 0.39 |
Ethnicity* | 0.97 | 0.62 – 1.45 | 0.88 |
Baseline CDAI | 0.99 | 0.98 – 1.00 | 0.06 |
Prednisone use | 1.45 | 1.06 – 1.97 | 0.02 |
RA duration>2 years | |||
Variable |
Odds ratio (OR) |
95% CI | p value |
Sex* | 0.65 | 0.48 – 0.87 | 0.005 |
Ethnicity* | 0.82 | 0.58 – 1.13 | 0.23 |
Baseline CDAI | 0.99 | 0.98 – 1.00 | 0.06 |
Length of follow up | 1.01 | 1.00 – 1.03 | 0.03 |
RA duration | 0.98 | 0.97 – 1.00 | 0.01 |
Pain VAS | 0.99 | 0.98 – 0.99 | <0.0001 |
Footnote:
All covariates adjusted for in the final model are listed as independent variables.
The referent group for these variables were as follows: Sex – female; ethnicity – Caucasian